Verastem Oncology
VSTM
$4.98
Share price
-3.49%
Change (1 day)
-58.01%
Change (1 year)
Categories
Revenue for Verastem Oncology (VSTM)
Revenue in 2024 (TTM): $10 Million USD
According to Verastem Oncology
's latest financial reports the company's current revenue (TTM 
) is $10 Million USD. an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Verastem Oncology from 2011 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $10 M | |
| 2023 | N/A | -100% |
| 2022 | $2.59 M | 26.45% |
| 2021 | $2.05 M | -97.68% |
| 2020 | $88.51 M | 407.11% |
| 2019 | $17.45 M | -34.67% |
| 2018 | $26.71 M | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $10.9 M | 9.08% | 🇺🇸 USA |
 | $63.62 B | 636,160.00% | 🇺🇸 USA |
 | $13.00 B | 129,989.00% | 🇺🇸 USA |
 | $40.18 B | 401,705.57% | 🇬🇧 UK |